Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling

FEBS Journal

Volumn 281, Issue 7, 2014, Pages 1750-1758

  Fan, Yu ^a   Shen, Bing ^a   Tan, Mingyue ^a   Mu, Xinyu ^a   Qin, Yan ^a   Zhang, Fang ^a   Liu, Yong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

bladder cancer; chemoresistance; cisplatin; UCA1; Wnt6

Indexed keywords

CISPLATIN; CYTOCHROME P450 1A1; LONG UNTRANSLATED RNA; ONCOPROTEIN; UNCLASSIFIED DRUG; UROTHELIAL CANCER ASSOCIATED 1; WNT PROTEIN; WNT6 PROTEIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RESISTANCE; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

MOUSE MAMMARY TUMOR VIRUS;

BLADDER CANCER; CHEMORESISTANCE; CISPLATIN; UCA1; WNT6;

AGED; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; HUMANS; MIDDLE AGED; RNA, LONG NONCODING; TRANSCRIPTION, GENETIC; UP-REGULATION; URINARY BLADDER NEOPLASMS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84897550048     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12737     Document Type: Article

References (36)

1. Lacey JV Jr, Devesa SS, &, Brinton LA, (2002) Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen 39, 82-88. (Pubitemid 34260479)
2. Luo M, Li Z, Wang W, Zeng Y, Liu Z, &, Qiu J, (2013) Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett 333, 213-221.
3. Egerod FL, Bartels A, Fristrup N, Borre M, Orntoft TF, Oleksiewicz MB, Brunner N, &, Dyrskjot L, (2009) High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression. BMC Cancer 9, 385.
4. Bo J, Yang G, Huo K, Jiang H, Zhang L, Liu D, &, Huang Y, (2011) microRNA-203 suppresses bladder cancer development by repressing bcl-w expression. FEBS J 278, 786-792.
5. Hirata H, Ueno K, Shahryari V, Tanaka Y, Tabatabai ZL, Hinoda Y, &, Dahiya R, (2012) Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer. PLoS ONE 7, e51056.
6. Pasin E, Josephson DY, Mitra AP, Cote RJ, &, Stein JP, (2008) Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history. Rev Urol 10, 31-43.
7. Kim WJ, Kim EJ, Kim SK, Kim YJ, Ha YS, Jeong P, Kim MJ, Yun SJ, Lee KM, Moon SK, et al,. (2010) Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer. Mol Cancer 9, 3.
8. James ND, Hussain SA, Hall E, Jenkins P, Tremlett J, Rawlings C, Crundwell M, Sizer B, Sreenivasan T, Hendron C, et al,. (2012) Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med 366, 1477-1488.
9. Xu N, Shen C, Luo Y, Xia L, Xue F, Xia Q, &, Zhang J, (2012) Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell. Biochem Biophys Res Commun 425, 468-472.
10. Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, et al,. (2011) Long non-coding RNA HOTAIR regulates Polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res 71, 6320-6326.
11. Moran VA, Perera RJ, &, Khalil AM, (2012) Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res 40, 6391-6400.
12. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al,. (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076.
13. Stojic L, Jasencakova Z, Prezioso C, Stutzer A, Bodega B, Pasini D, Klingberg R, Mozzetta C, Margueron R, Puri PL, et al,. (2011) Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells. Epigenetics Chromatin 4, 16.
14. Wang F, Li X, Xie X, Zhao L, &, Chen W, (2008) UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett 582, 1919-1927.
15. Kobune M, Chiba H, Kato J, Kato K, Nakamura K, Kawano Y, Takada K, Takimoto R, Takayama T, Hamada H, et al,. (2007) Wnt3/RhoA/ROCK signaling pathway is involved in adhesion-mediated drug resistance of multiple myeloma in an autocrine mechanism. Mol Cancer Ther 6, 1774-1784. (Pubitemid 46954054)
16. Flahaut M, Meier R, Coulon A, Nardou KA, Niggli FK, Martinet D, Beckmann JS, Joseph JM, Muhlethaler-Mottet A, &, Gross N, (2009) The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway. Oncogene 28, 2245-2256.
17. Noda T, Nagano H, Takemasa I, Yoshioka S, Murakami M, Wada H, Kobayashi S, Marubashi S, Takeda Y, Dono K, et al,. (2009) Activation of Wnt/β-catenin signalling pathway induces chemoresistance to interferon-α/5-fluorouracil combination therapy for hepatocellular carcinoma. Br J Cancer 100, 1647-1658.
18. Guo Y, Ying L, Tian Y, Yang P, Zhu Y, Wang Z, Qiu F, &, Lin J, (2013) miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. FEBS J 280, 4531-4538.
19. Su HY, Lai HC, Lin YW, Liu CY, Chen CK, Chou YC, Lin SP, Lin WC, Lee HY, &, Yu MH, (2010) Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway. Int J Cancer 127, 555-567.
20. Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW, Li MQ, Chen YC, Qian XP, Lu TJ, Yu LZ, et al,. (2006) Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res 12, 4851-4858. (Pubitemid 44338570)
21. Hwang JT, &, Kelly GM, (2012) GATA6 and FOXA2 regulate Wnt6 expression during extraembryonic endoderm formation. Stem Cells Dev 21, 3220-3232.
22. van Rhijn BW, Burger M, Lotan Y, Solsona E, Stief CG, Sylvester RJ, Witjes JA, &, Zlotta AR, (2009) Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol 56, 430-442.
23. Geng W, Ng KT, Sun CK, Yau WL, Liu XB, Cheng Q, Poon RT, Lo CM, Man K, &, Fan ST, (2011) The role of proline rich tyrosine kinase 2 (Pyk2) on cisplatin resistance in hepatocellular carcinoma. PLoS ONE 6, e27362.
24. Wang H, Tan G, Dong L, Cheng L, Li K, Wang Z, &, Luo H, (2012) Circulating miR-125b as a marker predicting chemoresistance in breast cancer. PLoS ONE 7, e34210.
25. Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y, Cheunsuchon P, Louis DN, &, Klibanski A, (2010) Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res 70, 2350-2358.
26. Gutschner T, &, Diederichs S, (2012) The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 9, 703-719.
27. Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et al,. (2003) MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22, 8031-8041. (Pubitemid 37175867)
28. Tano K, Mizuno R, Okada T, Rakwal R, Shibato J, Masuo Y, Ijiri K, &, Akimitsu N, (2010) MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett 584, 4575-4580.
29. WAF1/CIP1 expression. PLoS ONE 8, e77293.
30. Tsang WP, &, Kwok TT, (2007) Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells. Oncogene 26, 4877-4881. (Pubitemid 47093167)
31. Wang Y, Chen W, Yang C, Wu W, Wu S, Qin X, &, Li X, (2012) Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer. Int J Oncol 41, 276-284.
32. Yuan G, Regel I, Lian F, Friedrich T, Hitkova I, Hofheinz RD, Strobel P, Langer R, Keller G, Rocken C, et al,. (2013) WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells. Oncogene 32, 375-387.
33. Esaki T, Nakano S, Masumoto N, Fujishima H, &, Niho Y, (1996) Schedule-dependent reversion of acquired cisplatin resistance by 5-fluorouracil in a newly established cisplatin-resistant HST-1 human squamous carcinoma cell line. Int J Cancer 65, 479-484. (Pubitemid 26083256)
34. Xu N, Zhang J, Shen C, Luo Y, Xia L, Xue F, &, Xia Q, (2012) Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell. Biochem Biophys Res Commun 423, 826-831.
35. Yang C, Li X, Wang Y, Zhao L, &, Chen W, (2012) Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene 496, 8-16.
36. Zhang Y, Wei W, Cheng N, Wang K, Li B, Jiang X, &, Sun S, (2012) Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology 56, 1631-1640.